Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKesson
Fuji
QuintilesIMS
Julphar
Merck
AstraZeneca
Cantor Fitzgerald
Johnson and Johnson

Generated: January 24, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Dalcetrapib

« Back to Dashboard

US Patents for Dalcetrapib

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dalcetrapib ➤ Sign Up CETP activity inhibitors Japan Tobacco Inc. (Tokyo, JP) ➤ Sign Up
Dalcetrapib ➤ Sign Up Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals Aventis Pharma Deutschland GmbH (Frankfurt am Main, DE) ➤ Sign Up
Dalcetrapib ➤ Sign Up CETP activity inhibitor Japan Tobacco Inc. (Tokyo, JP) ➤ Sign Up
Dalcetrapib ➤ Sign Up Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals Aventis Pharma Deutschland GmbH (Frankfurt Am Main, DE) ➤ Sign Up
Dalcetrapib ➤ Sign Up Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors Pfizer Inc. (New York, NY) ➤ Sign Up
Dalcetrapib ➤ Sign Up Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments Sanofi-Aventis Deutschland GmbH (Frankfurt, DE) ➤ Sign Up
Dalcetrapib ➤ Sign Up N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use Aventis Pharma Deutschland GmbH (Frankfurt am Main, DE) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Dalcetrapib

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Dalcetrapib Argentina 015707 2017-02-12 ➤ Sign Up
Dalcetrapib Austria 338029 2017-02-12 ➤ Sign Up
Dalcetrapib Australia 5781898 2017-02-12 ➤ Sign Up
Dalcetrapib Australia 728979 2017-02-12 ➤ Sign Up
Dalcetrapib Brazil 9807222 2017-02-12 ➤ Sign Up
Dalcetrapib Brazil PI9807222 2017-02-12 ➤ Sign Up
Dalcetrapib Canada 2280708 2017-02-12 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
McKinsey
Fuji
Cantor Fitzgerald
Fish and Richardson
Teva
QuintilesIMS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: